Clin2
NCT07490405Possibly a fitNot yet recruiting

Comparing two procedures for cirrhosis bleeding and enlarged spleen

Liver Cirrhosis

Treatments studied

Part of Digestive system clinical trials.

This study compares two procedures to treat bleeding from enlarged veins in the esophagus or stomach for people with cirrhosis and an overactive spleen. The goal is to see which approach reduces bleeding risk and improves blood counts over time.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
140 people
Ages
18 years to 75 years
Study type
Observational

Who can take part

  • You have cirrhosis (scarring of the liver) with high blood pressure in the vein that carries blood to the liver.
  • You have had bleeding from swollen veins in your esophagus or stomach, and it came back after a treatment called banding (EVL).
  • Your spleen is overactive, causing low platelets or white blood cells.
  • Your liver function is in a good range (Child-Pugh class A or B).
  • You are between 18 and 75 years old.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07587671Not yet recruiting
Preventing repeat bleeding from veins in cirrhosis

This study compares two ways to prevent future bleeding from enlarged veins in the esophagus or stomach in people with liver cirrhosis. One method uses a small tube (called TIPS) to reduce pressure in the liver, and the other combines a banding procedure with medication. The goal is to see which approach works better.

Chengdu
NCT07253389Recruiting
Comparing two TIPS techniques to prevent variceal rebleeding in cirrhosis

This trial tests a slightly smaller TIPS stent (underdilated) against the standard size to see which is better at preventing another variceal bleed in people with cirrhosis and liver scarring. It aims to find the safest way to lower pressure in the veins while reducing side effects.

Xi'an, Shaanxi
NCT07129447Not yet recruiting
Day-care endoscopic treatment for bleeding risk from varices in cirrhosis

This study tests whether treating enlarged veins in the food pipe or stomach (called varices) in a day-care unit, without an overnight hospital stay, is safe and feasible for people with cirrhosis. The treatment aims to prevent these veins from bleeding.

NCT07755059Not yet recruiting
Blocking the splenic artery for hard-to-treat belly fluid in liver cirrhosis

This trial tests a procedure called splenic artery embolization (blocking part of the blood supply to the spleen) to reduce belly fluid buildup in people with advanced liver disease. It may help if your ascites has not improved with standard treatments and you are not a candidate for TIPS.

Boston, Massachusetts
NCT07470515Not yet recruiting
Guided TIPS procedure for liver complications

This study tests a new way to guide a procedure called TIPS, which helps relieve pressure in the liver caused by fluid buildup or bleeding. The new guidance method may make the procedure safer or more precise.

Innsbruck, Tyrol
NCT07588334Not yet recruiting
LSD for bleeding risk in cirrhosis patients with enlarged spleen

This study tests a surgery (LSD) in people with liver cirrhosis who have had bleeding from enlarged veins in the food pipe or stomach. It looks at whether the surgery helps improve blood fat levels over two years, which might lower future risks.

Yangzhou, Jiangsu

Hear when a new Liver Cirrhosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.